Pyoderma gangrenosum

E Maverakis, AV Marzano, ST Le, JP Callen… - Nature Reviews …, 2020 - nature.com
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that presents with rapidly
developing, painful skin ulcers hallmarked by undermined borders and peripheral erythema …

Pyoderma gangrenosum: a review of pathogenesis and treatment

C Ahn, D Negus, W Huang - Expert review of clinical immunology, 2018 - Taylor & Francis
Introduction: Pyoderma gangrenosum (PG) is a complex neutrophilic dermatosis that can
occur as an idiopathic disease, in association with systemic conditions such as inflammatory …

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial

AD Ormerod, KS Thomas, FE Craig, E Mitchell… - bmj, 2015 - bmj.com
Objective To determine whether ciclosporin is superior to prednisolone for the treatment of
pyoderma gangrenosum, a painful, ulcerating skin disease with a poor evidence base for …

[PDF][PDF] Effective strategies for the management of pyoderma gangrenosum: a comprehensive review.

S Fitzmaurice, C Duong, HE Young, J Fergus… - Acta dermato …, 2015 - Citeseer
526 F. Patel et al. of the disease usually requires long-term maintenance therapy to prevent
relapses from occurring. Although Brunsting and coworkers were incorrect in proposing an …

Pyoderma gangrenosum: challenges and solutions

A Gameiro, N Pereira, JC Cardoso… - Clinical, cosmetic and …, 2015 - Taylor & Francis
Pyoderma gangrenosum (PG) is a rare disease, but commonly related to important
morbidity. PG was first assumed to be infectious, but is now considered an inflammatory …

Canakinumab in adults with steroid‐refractory pyoderma gangrenosum

AGA Kolios, JT Maul, B Meier, K Kerl… - British Journal of …, 2015 - academic.oup.com
Background Pyoderma gangrenosum (PG) is a rare, neutrophilic, ulcerative skin disease
that is difficult to treat, especially when unresponsive to steroids. Objectives To determine …

[HTML][HTML] Practical aspects of the diagnosis and management of pyoderma gangrenosum

B Chen, W Li, B Qu - Frontiers in Medicine, 2023 - frontiersin.org
Pyoderma gangrenosum (PG) is a rare autoinflammatory ulcerative neutrophilic skin
disease. Its clinical presentation is a rapidly progressing painful skin ulcer with ill-defined …

Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials

ACR Partridge, JW Bai, CF Rosen… - British journal of …, 2018 - academic.oup.com
Background Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with substantial
morbidity. There is no consensus on gold‐standard treatments. Objectives To review the …

Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: the Mayo Clinic experience, 1996 through 2013

NS Barbosa, SN Tolkachjov, RA El-Azhary… - Journal of the American …, 2016 - Elsevier
Background There are limited large case series of peristomal pyoderma gangrenosum
(PPG), an uncommon cause of recalcitrant peristomal ulceration. Objective We sought to …

Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts

P Al Ghazal, J Dissemond - JDDG: Journal der Deutschen …, 2015 - Wiley Online Library
Background There are currently no therapeutic guidelines with respect to pyoderma
gangrenosum (PG). Material and methods In order to systematically record currently …